Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy

Strahlentherapie und Onkologie

Volumn 182, Issue 5, 2006, Pages 289-292

  Souchon, Rainer ^a,f   Gertenbach, Ulrich ^a   Dieckmann, Klaus Peter ^b   Hahn, Eugen ^a   Ruwe, Markus ^c   Stambolis, Christos ^c   Loy, Volker ^d   Claßen, Johannes ^e  

^a AKH Hagen gGmbH ^*  (Germany)

^b ALBERTINEN KRANKENHAUS   (Germany)

^c Institute of Pathology   (Germany)

^d Klinikum Am Urban   (Germany)

^e St Vincentius Kliniken gAG   (Germany)

^f AKH Hagen gGmbH   (Germany)

Author keywords

Chemoprevention of testicular cancer; Metachronous testicular germ cell cancer; Testicular biopsy; Testicular intraepithelial neoplasia (TIN)

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CASE REPORT; CHEMOPROPHYLAXIS; FALSE NEGATIVE RESULT; GERM CELL TUMOR; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; METACHRONOUS TESTICULAR GERM CELL CANCER; ORCHIECTOMY; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; TESTICULAR INTRAEPITHELIAL NEOPLASIA; TESTIS BIOPSY; TESTIS CANCER; TESTIS TUMOR; TUMOR LOCALIZATION; VISCERAL METASTASIS;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FALSE NEGATIVE REACTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TESTIS; TIME FACTORS;

EID: 33646558920     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1516-x     Document Type: Article

References (29)

1. Berthelsen JG, Skakkebaek NE. Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 1981;15:165-8.
2. Boehmer D, Badakhshi H, Kuschke W, et al. Testicular dose in prostate cancer radiotherapy. Impact on impairment of fertility and hormonal function. Strahlenther Onkol 2005;181:179-84.
3. Christensen TB, Daugaard G, Geertsen PF, et al. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998;9:657-60.
4. Classen J, Dieckmann KP, Bamberg M, et al. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia (TIN): preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003;88:828-31.
5. Classen J, Dieckmann KP, Loy V, et al. Die testikuläre intraepitheliale Neoplasie (TIN) - Indikation zur Strahlentherapie? Strahlenther Onkol 1998;174:173-7.
6. Classen J, Dieckmann K-P, Loy V, et al. Strahlentherapie der testikulären intraepithelialen Neoplasie (TIN): erste Ergebnisse der deutschen Studie zur Dosisreduktion. Strahlenther Onkol 2003;179:Sondernr 1:19.abstract #113V.
7. Claßen J, Spillner P, Knutzen B, et al. Organerhaltende Therapie bei testikulären Keimzelltumoren - eine Alternative zur Ablatio testis? Strahlenther Onkol 2004;180:Suppl 1:54.abstract #PV-073.
8. Dieckmann KP, Heinemann V, Frey U, et al. How harmful is contralateral testicular biopsy? An analysis of serial imaging studies and a prospective evaluation of surgical complications. Eur Urol 2005;48:662-72.
9. Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996;14:3126-32.
10. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999;83:815-22.
11. Dieckmann KP, Souchon R, Hahn E, et al. False-negative biopsies for testicular intraepithelial neoplasia. J Urol 1999;162:364-8.
12. Fietkau R. Ductal carcinoma in situ of the breast. Increasing importance of radiotherapy as a part of the therapy approach. Strahlenther Onkol 2004;180:682-9.
13. Fossa SD, Chen J, Schonfeld SJ, et al. Risk of contralateral testicular cancer: a population-based study of 29515 U.S. men. J Natl Cancer Inst 2005;97:1056-66.
14. Herr HW, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 1997;158:1331-4.
15. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, et al. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 2005;16:863-8.
16. International Germ Cell Cancer Collaborative Group (IGCCCG). The International Germ Cell Consensus Classification: a prognostic factor based staging system for metastatic germ cell cancer. J Clin Oncol 1997;15:594-603.
17. Janda M, Newman B, Obermair A, et al. Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol 2004;180:78-83.
18. Kliesch S, Thomaidis T, Schütte G, et al. Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 2003;111:70-5.
19. Linke J, Loy V, Dieckmann KP. Prevalence of testicular intraepithelial neoplasia in healthy males. J Urol 2005;173:1577-9.
20. Loy V, Wigand I, Dieckmann KP. Incidence and distribution of carcinoma in situ in testes removed for germ cell tumour: possible inadequacy of random testicular biopsy in detecting the condition. Histopathology 1990;16:198-200.
21. Maase H von der, Rorth M, Walbom-Jorgensen S, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J [Clin Res] 1986;293:1398-401.
22. Ostau C von, Krege S, Hartmann M, et al. Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies. Scand J Urol Nephrol 2001;35:430-1.
23. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377-99.
24. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet 1972;2:516-7.
25. Sobin LH, Wittekind CH, eds. UICC: TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
26. Souchon R, Claßen J, Schmidberger H. EbM-basierte Indikationen zur Radiotherapie von testikulären Keimzellmalignomen. Urologe A 2004;43:1500-6.
27. Souchon R, Krege S, Schmoll HJ, et al. Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren: Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM). Strahlenther Onkol 2000;176:388-405.
28. Wanderas EH, Fossa SD, Tretli S. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 1997;33:253-62.
29. Winstanley AM, Mikuz G, Debruyne F, et al. Handling and reporting of biopsy and surgical specimens of testicular cancer. Eur Urol 2004;45:564-73.